SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALPIAZ, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.195
EU - Europa 3.081
AS - Asia 2.341
SA - Sud America 39
AF - Africa 9
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.676
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.172
CN - Cina 1.146
UA - Ucraina 930
TR - Turchia 519
IT - Italia 501
SG - Singapore 464
DE - Germania 459
GB - Regno Unito 363
SE - Svezia 258
FI - Finlandia 206
PL - Polonia 176
FR - Francia 69
ID - Indonesia 50
IN - India 50
HK - Hong Kong 28
CZ - Repubblica Ceca 25
BR - Brasile 22
CA - Canada 22
PK - Pakistan 21
BE - Belgio 18
IR - Iran 16
NL - Olanda 16
AT - Austria 14
VN - Vietnam 14
CO - Colombia 12
RU - Federazione Russa 12
JP - Giappone 8
IE - Irlanda 7
IQ - Iraq 7
EG - Egitto 5
KR - Corea 5
LT - Lituania 5
RO - Romania 5
TH - Thailandia 5
AU - Australia 4
CH - Svizzera 4
HU - Ungheria 4
ZA - Sudafrica 4
EU - Europa 3
GR - Grecia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
DK - Danimarca 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
MN - Mongolia 1
MX - Messico 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 16.676
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.460
Fairfield 1.336
Jacksonville 1.010
Houston 998
Chandler 851
Ashburn 624
Ann Arbor 622
Wilmington 556
Seattle 526
Cambridge 480
Izmir 334
Singapore 315
Nanjing 294
Princeton 226
Beijing 195
Ferrara 188
Boardman 187
Warsaw 176
San Diego 116
Addison 103
Nanchang 96
Milan 91
New York 83
Shenyang 78
Hebei 73
Shanghai 69
Tianjin 51
Changsha 49
Falls Church 49
Jakarta 49
Bremen 47
Redwood City 46
San Mateo 46
Los Angeles 45
Dearborn 43
Santa Clara 42
Jiaxing 35
Kunming 32
Norwalk 31
Mountain View 28
London 27
Jinan 26
Helsinki 23
Hong Kong 22
Zhengzhou 22
Philadelphia 19
Auburn Hills 18
Ningbo 18
Tappahannock 16
Washington 16
Bologna 15
Brussels 15
Düsseldorf 15
Olomouc 15
Verona 15
Indiana 13
Lanzhou 13
Orange 13
Rome 13
Guangzhou 11
Vienna 11
Hangzhou 10
Islamabad 10
Leawood 10
Toronto 10
Wuhan 10
Augusta 9
Frankfurt am Main 9
Dong Ket 8
Guarda Veneta 8
Hyderabad 8
Redmond 8
Taizhou 8
Dallas 7
Medellín 7
Munich 7
Amsterdam 6
Changchun 6
Des Moines 6
Hefei 6
Monmouth Junction 6
Ottawa 6
Ardabil 5
Bogotá 5
Brno 5
Dublin 5
Gurgaon 5
Ho Chi Minh City 5
Islington 5
Paris 5
Argenta 4
Haikou 4
Itajaí 4
Jaipur 4
Masi Torello 4
Modena 4
Rovere Veronese 4
Taiyuan 4
Bolzano 3
Chicago 3
Totale 12.279
Salva come PNG Salva come JPEG
Nome #
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 245
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 201
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 168
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 155
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 151
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 147
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 147
Physicochemical stability of cabazitaxel and docetaxel solutions 147
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 138
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 131
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 128
Conjugation of aspirin with vitamin C: uptake and stability studies 127
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 126
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 126
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 125
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 123
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 122
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. 121
Solid microparticles based on chitosan or methyl-beta-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 120
Binding thermodynamics at A1 and A2A adenosine receptors 118
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 118
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 116
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs. 114
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 112
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 111
Conformational Aspects of Human Formyl-peptide Receptor Agonists 111
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres. 109
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 109
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 109
Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study 109
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight 108
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 108
Progress in drug delivery to the central nervous system by the prodrug approach 108
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A 1 receptors of LUF5831, a novel nonadenosine-like agonist 106
null 106
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 105
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 105
Exploring the Use of Spray Congealing to Produce Solid Dispersions with Enhanced Indomethacin Bioavailability 105
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 104
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor 104
Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents 104
null 103
Thermodynamics of full agonist, partial agonist and antagonist binding to wild type and mutant adenosine A1 receptors. 103
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review 103
Binding thermodynamics of 5-HT(1A) receptor ligands 102
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 102
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 101
Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils 101
Conformational aspects of human formylpeptide receptor antagonists 101
Temperature dependence of the affinity enhancement of selective adenosine A1 receptor agonism: A thermodynamic analysis 100
Dopamine-sensitive adenylyl cyclases in neuronal development: physiopathological and pharmacological implications. 100
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 100
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 98
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 97
Binding thermodynamics of adenosine A2a receptor ligands 97
Characterization of A2A Adenosine Receptors in Human Lymphocyte Membranes by [3H]-SCH 58261 Binding 97
Pharmacological and Biochemical Characterization of Purified A2A Adenosine Receptors in Human Platelet Membranes by [3H]-CGS 21680 Binding 96
Determination of the adenosine A1 agonist N6-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC 96
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles 96
Nuclear Retinoic Acid Receptor Beta as a Tool in Chemoprevention Trials 96
Biochemical and pharmacological characterization of periodate-oxidized adenosine analogues at adenosine A1 receptors. 96
Thermodynamics of 5-HT3 receptor binding discriminates agonistic from antagonistic behaviour 93
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy (R)) in allergic rhinitis treatment 93
null 93
Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H] SCH 58261 binding 92
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in-vivo preclinical pharmacokinetic study 92
null 91
Temperature dependence and GABA modulation of b-carboline binding to rat cerebellum benzodiazepine receptors. 91
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 91
Pharmacological, biochemical and thermodynamic characterization of purified adenosine A2A receptors in human platelet membranes by [3H] CGS 21680 binding 91
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 90
Influence of secondary preparative parameters and aging effects on PLGA particle size distribution: a sedimentation field flow fractionation investigation. 89
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 89
Binding thermodynamics of serotonin to rat brain 5HT1A, 5HT2A and 5HT3 receptors 89
null 88
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 88
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 87
Odorants could elicit repair processes in melanized neuronal and skin cells 86
Full and partial agonists and thermodynamic binding parameters of adenosine A1 receptor ligands 85
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 84
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 84
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 84
Incorporation of the polar antiischemic drug N6-cyclopentyladenosine in solid lipid microparticles 83
null 83
null 83
Nasal administration and brain targeting of an antiischemic agent 82
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 82
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 82
null 81
Adenosine A1 receptor: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system 81
null 79
METODO PER MODULARE L'ASSORBIMENTO FAGOCITARIO DI UN PRINCIPIO ATTIVO O UN SUO PRECURSORE DA PARTE DI MACROFAGI 78
The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability 78
Adenosine analogs prodrugs: design, synthesis and chemico-physical characterization of N6-cyclopentyladenosine (CPA) derivatives 77
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 77
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 77
null 77
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 77
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 76
Can Thermodynamic Measurements of Receptor Binding Yield Information on Drug Affinity and Efficacy? 76
Totale 10.431
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.012
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.772
Totale 77.784
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.586 0 0 0 494 207 391 270 374 244 399 129 78
2020/20212.762 221 314 186 253 94 272 80 297 106 445 364 130
2021/20221.971 50 228 148 120 87 85 77 102 76 163 180 655
2022/20231.972 226 94 53 255 379 306 59 155 249 15 115 66
2023/2024989 120 133 57 24 93 111 35 38 15 19 33 311
2024/2025666 98 89 379 100 0 0 0 0 0 0 0 0
Totale 16.948